1. Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy's initial experience with its first 100 patients. (September 2022) Authors: Tselikas, Lambros; Dardenne, Antoine; de Baere, Thierry; Faron, Matthieu; Ammari, Samy; Farhane, Siham; Suzzoni, Steve; Danlos, François-Xavier; Raoult, Thibault; Susini, Sandrine; Al Shatti, Nael; Mouraud, Severine; Deschamps, Frédéric; Kobe, Adrian; Delpla, Alexandre; Roux, Charles; Baldini, Ca... Journal: European journal of cancer Issue: Volume 172(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial. Issue 4 (April 2021) Authors: Pollard, Andrew J; Launay, Odile; Lelievre, Jean-Daniel; Lacabaratz, Christine; Grande, Sophie; Goldstein, Neil; Robinson, Cynthia; Gaddah, Auguste; Bockstal, Viki; Wiedemann, Aurelie; Leyssen, Maarten; Luhn, Kerstin; Richert, Laura; Bétard, Christine; Gibani, Malick M; Clutterbuck, Elizabeth A; ... Journal: Lancet infectious diseases Issue: Volume 21:Issue 4(2021) Page Start: 493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗